J Stroke.  2024 Jan;26(1):125-128. 10.5853/jos.2023.03349.

Haptoglobin Gene Polymorphism Is Associated With Lower Postoperative Cardiovascular Risk in Carotid Stenosis Patients

• Mohsen Y
• Shami A
• Edsfeldt A
• Sun J
• Gonçalves I

• KMID: 2551357
• DOI: http://doi.org/10.5853/jos.2023.03349

Figure

• 

  Figure 1. The association between Hp1S and atherosclerosis. (A) Kaplan-Meier curves depicting the time to cardiovascular events (CVE) for Hp1S carriers and non-carriers in the entire cohort (left) and among symptomatic patients (right). (B) Representative human atherosclerotic plaque tissue section images showing a greater plaque area stained positive for the smooth muscle cell marker alpha-actin (in brown) in plaques from Hp1S carrier compared to plaques from non-carrier patients. Positively stained plaque tissue sections on the left and isotype-control tissue sections on the right.

Reference

References

1. Smithies O, Connell GE, Dixon GH. Inheritance of haptoglobin subtypes. Am J Hum Genet. 1962; 14:14–21.

2. Boettger LM, Salem RM, Handsaker RE, Peloso GM, Kathiresan S, Hirschhorn JN, et al. Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels. Nat Genet. 2016; 48:359–366.

3. Merkler A, Sertic´ J, Bazina Martinovic´ A, Križ T, Milicˇic´ I, Šimic´ M, et al. Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke. Gene. 2020; 752:144786.

4. Ijäs P, Saksi J, Soinne L, Tuimala J, Jauhiainen M, Jula A, et al. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis. 2013; 230:228–234.

5. Syreeni A, Dahlström EH, Hägg-Holmberg S, Forsblom C, Eriksson MI, Harjutsalo V, et al. Haptoglobin genotype does not confer a risk of stroke in type 1 diabetes. Diabetes. 2022; 71:2728–2738.

6. Cahill LE, Jensen MK, Chiuve SE, Shalom H, Pai JK, Flint AJ, et al. The risk of coronary heart disease associated with glycosylated hemoglobin of 6.5% or greater is pronounced in the haptoglobin 2-2 genotype. J Am Coll Cardiol. 2015; 66:1791–1799.

7. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, et al. Structure-function analysis of the antioxidant properties of haptoglobin. Blood. 2001; 98:3693–3698.

8. Carew AS, Levy AP, Ginsberg HN, Coca S, Lache O, Ransom T, et al. Haptoglobin phenotype modifies the influence of intensive glycemic control on cardiovascular outcomes. J Am Coll Cardiol. 2020; 75:512–521.

9. Naryzny SN, Legina OK. Haptoglobin as a biomarker. Biochemistry Mosc Suppl B Biomed Chem. 2021; 15:184–198.